P18. Predictive role of serum tumor markers NSE and TK in patients with advanced-stage NSCLC treated with EGFR-TKIs

BACKGROUND: Targeted treatment based on tyrozine kinase inhibitors (TKI) directed at epidermal growth factor receptor (EGFR) represents a novel effective tool in management of advanced-stage non-small cell lung cancer (NSCLC). Although, activating EGFR gene mutations represent currently the stronges...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Fiala, Ondrej, Pesek, Milos, Finek, Jindrich, Benesova, Lucie, Minarik, Marek, Bortlicek, Zbynek, Topolcan, Ondrej
Format: Artigo
Idioma:Inglês
Publicat: Pioneer Bioscience Publishing Company 2014
Matèries:
CELCC 2014 Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367793/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars